Target intelligence / Profile preview

Small ribosomal subunit protein uS14 (uS14)

Target
uS14
Molecular classification
Ribosomal protein, Structural protein, Other
01

Overview

Small ribosomal subunit protein uS14 is a highly conserved structural protein essential for the assembly and function of the small ribosomal subunit (30S in bacteria, 40S in eukaryotes)[4][5][7]. It binds to ribosomal RNA (16S in bacteria; 18S in eukaryotes) and supports the ribosome’s structure and its role in translation initiation and elongation[4][7]. In eukaryotes, it is known as 40S ribosomal protein S29, encoded by the RPS29 gene in humans[9]. Mutations in RPS29 cause Diamond–Blackfan anemia, highlighting the protein’s essential role in ribosome biogenesis and erythropoiesis[9]. The protein has a compact, mostly invariable globular structure with a zinc finger domain for rRNA interaction, though variable terminal extensions may occur across species[2]. At present, this protein is not considered a direct therapeutic target, as it plays a fundamental, ubiquitous role in cell viability[4][9].

Other names
30S ribosomal protein S14 (bacteria)40S ribosomal protein S29 (eukaryotes, including humans)rpsN (bacterial gene)rpsZ (bacterial gene alternative)RPS29 (human gene)
02

Mechanism of action

Inhibition of protein synthesis (for hypothetical drugs targeting this protein, mechanism would likely involve disruption of ribosome assembly or function; no well-defined drugs directly targeting uS14 reported)[4]

03

Biological functions

Protein synthesisAssembly of small ribosomal subunitrRNA bindingStructural constituent of ribosome
04

Disease associations

Diamond–Blackfan anemia (mutations in human RPS29)[9]Potential associations with cancer (variable expression in some tumors, e.g., colorectal cancer)[9]Other
05

Safety considerations

Targeting this protein may cause broad cytotoxicity, anemia, or block cellular protein synthesis due to its essential and ubiquitous role in ribosomal function[9]Mutations result in congenital anemia (e.g., Diamond–Blackfan anemia)[9]
06

Interacting drugs

2-Methylthio-N6-isopentenyl-adenosine-5'-monophosphate (experimental, activity unknown)[4]
07

Biomarkers

RPS29 mutations as a biomarker for Diamond–Blackfan anemia[9]

Beyond the preview

Go deeper on Small ribosomal subunit protein uS14 (uS14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small ribosomal subunit protein uS14 (uS14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call